In the first described uveal melanoma mouse model, an oncogenic Gnaq mutant under the control of the Rosa26 promoter was conditionally expressed by the cre recombinase under the control of melanocyte specific-promoter Mitf, and could initiate tumors which progressed to intravasation and metastases in 100% offspring [56]. The gene discussed is GNAQ; the disease is uveal melanoma.